Evidence map›Paper›PMID 37100150›Full record

ArticleThe Science of the total environment2023

Capturing the SARS-CoV-2 infection pyramid within the municipality of Rotterdam using longitudinal sewage surveillance.

Miranda de Graaf, Jeroen Langeveld, Johan Post, Christian Carrizosa, Eelco Franz, Ray W Izquierdo-Lara, Goffe Elsinga, Leo Heijnen, Frederic Been, Janko van Beek and 6 more

Abstract read
In one paragraph

Article in The Science of the total environment, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed.

  1. Comparing Wastewater-Based and Case-BasedEpidemiology and infection · 2026
    Article
  2. Article
  3. Article
  4. Article
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

16 authors.

Miranda de GraafDepartment of Viroscience, Erasmus University Medical Center, Rotterdam, the Netherlands; Pandemic and Disaster Preparedness Centre Rotterdam and Delft, the Netherlands. Electronic address: m.degraaf@erasmusmc.nl.
Jeroen LangeveldPartners4urbanwater, Nijmegen, the Netherlands; Delft University of Technology, Stevinweg 1, 2628 CN Delft, the Netherlands.
Johan PostPartners4urbanwater, Nijmegen, the Netherlands.
Christian CarrizosaCentre for Infectious Disease Control, National Institute for Public Health and the Environment (RIVM), Bilthoven, the Netherlands; Department of Medical Genetics, Oslo University Hospital, Oslo, Norway.
Eelco FranzCentre for Infectious Disease Control, National Institute for Public Health and the Environment (RIVM), Bilthoven, the Netherlands.
Ray W Izquierdo-LaraDepartment of Viroscience, Erasmus University Medical Center, Rotterdam, the Netherlands.
Goffe ElsingaKWR Water Research Institute, Groningenhaven 7, 3433 PE Nieuwegein, the Netherlands.
Leo HeijnenKWR Water Research Institute, Groningenhaven 7, 3433 PE Nieuwegein, the Netherlands.
Frederic BeenKWR Water Research Institute, Groningenhaven 7, 3433 PE Nieuwegein, the Netherlands.
Janko van BeekDepartment of Viroscience, Erasmus University Medical Center, Rotterdam, the Netherlands.
Remy SchilperoortPartners4urbanwater, Nijmegen, the Netherlands.
Rianne VriendRegional Public Health Service Rotterdam-Rijnmond, Rotterdam, the Netherlands.
Ewout FanoyRegional Public Health Service Rotterdam-Rijnmond, Rotterdam, the Netherlands.
Evelien I T de SchepperDepartment of General Practice, Erasmus University Medical Center, Rotterdam, the Netherlands.
Marion P G KoopmansDepartment of Viroscience, Erasmus University Medical Center, Rotterdam, the Netherlands; Pandemic and Disaster Preparedness Centre Rotterdam and Delft, the Netherlands.
Gertjan MedemaPandemic and Disaster Preparedness Centre Rotterdam and Delft, the Netherlands; KWR Water Research Institute, Groningenhaven 7, 3433 PE Nieuwegein, the Netherlands; Delft University of Technology, Stevinweg 1, 2628 CN Delft, the Netherlands.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Despite high vaccination rates in the Netherlands, severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) continues to circulate. Longitudinal sewage surveillance was implemented along with the notification of cases as two parts of the surveillance pyramid to validate the use of sewage for surveillance, as an early warning tool, and to measure the effect of interventions. Sewage samples were collected from nine neighborhoods between September 2020 and November 2021. Comparative analysis and modeling were performed to understand the correlation between wastewater and case trends. Using high resolution sampling, normalization of wastewater SARS-CoV-2 concentrations, and 'normalization' of reported positive tests for testing delay and intensity, the incidence of reported positive tests could be modeled based on sewage data, and trends in both surveillance systems coincided. The high collinearity implied that high levels of viral shedding around the onset of disease largely determined SARS-CoV-2 levels in wastewater, and that the observed relationship was independent of variants of concern and vaccination levels. Sewage surveillance alongside a large-scale testing effort where 58 % of a municipality was tested, indicated a five-fold difference in the number of SARS-CoV-2-positive individuals and reported cases through standard testing. Where trends in reported positive cases were biased due to testing delay and testing behavior, wastewater surveillance can objectively display SARS-CoV-2 dynamics for both small and large locations and is sensitive enough to measure small variations in the number of infected individuals within or between neighborhoods. With the transition to a post-acute phase of the pandemic, sewage surveillance can help to keep track of re-emergence, but continued validation studies are needed to assess the predictive value of sewage surveillance with new variants. Our findings and model aid in interpreting SARS-CoV-2 surveillance data for public health decision-making and show its potential as one of the pillars of future surveillance of (re)emerging viruses.

Indexed as

COVID-19HumansSARS-CoV-2SewageWastewaterWastewater-Based Epidemiological MonitoringSewageWastewaterEarly warning systemsPublic healthSARS-COV-2SewageSurveillance

Identifiers

PMID37100150
PMCPMC10125208

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.